Pt Itama Ranoraya Tbk Reports Earnings Results for the Nine Months Ended September 30, 2020
October 18, 2020 at 04:08 pm
Share
PT Itama Ranoraya Tbk announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was IDR 141,056.593 million compared to IDR 128,952.865 million a year ago. Operating income was IDR 11,356.313 million compared to IDR 8,614.551 million a year ago. Net income was IDR 35,467.662 million compared to IDR 6,165.250 million a year ago. Basic earnings per share was IDR 24 compared to IDR 14 a year ago.
PT Itama Ranoraya Tbk is an Indonesia-based healthcare company, which is engaged in offering healthcare solutions. The Company operates in the field of wholesale trading of laboratory equipment, pharmaceutical equipment, and medical devices for humans. The Company carries out its operations through four products, namely the non-electromedical sterile medical devices, in-vitro diagnostic, electromedical sterile medical devices, and other products. Its business segment focuses on in-vitro diagnostic (IVD), medical imaging, surgical instrument and disposable, critical care, blood banking and transfusion, cardiovascular, brain management, cancer, urology, and maternal and neonatal care. Its products include Oneject, Abbott, Terumo, Becton Dickinson (BD), HMD, Vestfrost, Balmed, iGene, AVIMAC, and HemoCue.